Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is the most common benign tumor in males. Androgen/androgen receptor (AR) signaling plays a key role in the development of BPH; its alterations cause an imbalance between prostate cell growth and apoptosis. Furthermore, chronic inflammation and oxidative stress, wh...

Full description

Bibliographic Details

Published in:	Antioxidants
Main Authors:	Ramona D’Amico, Tiziana Genovese, Marika Cordaro, Rosalba Siracusa, Enrico Gugliandolo, Alessio Filippo Peritore, Livia Interdonato, Rosalia Crupi, Salvatore Cuzzocrea, Rosanna Di Paola, Roberta Fusco, Daniela Impellizzeri
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Subjects:	benign prostatic hyperplasia androgen receptor palmitoylethanolamide baicalein inflammation oxidative stress
Online Access:	https://www.mdpi.com/2076-3921/10/7/1014